MAR . 30 2018
Peking University, March 30, 2018: On March 16, 2018, the latest research findings by Professor Huang Xiaojun, Director of Peking University Institute of Hematology (PKUIH) and Dean of Hematology Department of Peking University People’s Hospital, were published by Blood, the international top journal in hematology, as the cover highlight. The paper was titled “Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients” with Associate Professor Kong Yuan from PKUIH as its first author.

The cover image of Blood: the result picture of Professor Huang Xiaojun’s research, which shows atorvastatin treatment promotes megakaryocytopoiesis via repairing corticosteroid-sensitive immune thrombocytopenia to reduce bone marrow endothelial progenitor cells in patients.

The study found for the first time that atorvastatin can enhance the number and function of bone marrow endothelial progenitor cells (BM EPCs) in corticosteroid-resistant immune thrombocytopenia (ITP) patients, and thus repairs megakaryocytopoiesis, increases platelet production, and reduces hemorrhage, so as to provide a promising therapy for ITP patients.

It was the first time for researchers to reveal a brand new pathogenesis and clinical intervention strategy for corticosteroid-resistant ITP in terms of BM EPCs. The study set the theoretical foundation for a new system of prevention and treatment of corticosteroid-resistant ITP and will hopefully improve clinical prognosis.

Invited by Blood, Professor Ishac Nazy from Mc Master University, Canada, and Professor Adam Cuker from University of Pennsylvania, US, commented in the same issue: “The findings of Professor Huang Xiaojun’s team serve as a reminder that ITP is not one disease but rather a heterogeneous group of diseases with varying disease mechanisms. Their study unravels the manifold mechanisms of ITP, offers a new therapy for the clinical intervention of corticosteroid-resistant ITP, and paves the way for prospective randomized controlled trial.”

Previously in 2016, Professor Jane L Liesveld from University of Rochester commented in Blood (Vol.128, 2016): “Professor Huang Xiaojun’s team has made a step forward in graft failure from complicated mechanism to therapeutic approach.” And Professor Monica L Hulbert from Washington University wrote in the Editor’s Choice of Science Translational Medicine (2016) that the pioneering discovery of statin could be applied in the prevention or therapy of graft failure.

Professor Huang Xiaojun’s research team of the microenvironment of bone marrow

Written by: Lang Lang
Edited by: Liu Xin
Source: Peking University People’s Hospital
ML聚合app下载 Copyright tx_-1 tx_lh15 c_tx0"> © 2015 Peking University
Peking University, No.5 Yiheyuan Road Haidian District, Beijing, P.R.China 100871
京公网安备 110402430047 号
火爆社区app下载 薰衣草直播下载app 彩云直播app下载 微杏app下载 七秒鱼直播下载app 快狐短视频app下载 恋人直播下载app 午夜直播app下载 金鱼直播下载app 红高粱直播app下载 花样视频下载app视频免费最新 猫咪软件下载app 泡泡直播app下载 Avboboapp下载 卡哇伊app下载 菠萝蜜下载app 千层浪直播下载app 后宫视频下载app 小怪兽直播app下载 抖阴app下载 成版人短视频app下载 富二代f2抖音下载app 食色下载app 柠檬直播下载app视频免费最新 葫芦娃app下载 梦幻直播app下载 茄子直播下载app 男人本色西瓜视频下载app 小米粒直播下载app 好嗨哟直播下载app 向日葵app下载 91视频下载app 夜猫视频下载app 夜猫视频app下载 荔枝视频下载app 雨燕直播下载app 香蕉下载app 台湾swag下载app 小公主直播app下载 尤蜜app下载 七秒鱼直播下载app 梦幻直播app下载 bobo直播下载app 年轻人片下载app视频免费最新 小奶猫app下载 色秀直播app下载 7秒鱼app下载 菠萝菠萝蜜视频app下载 盘他app下载 蓝精灵直播下载app 和欢视频下载app 好嗨哟直播app下载 趣播app下载 么么直播app下载 快猫app下载 咪咪直播app下载 成版人抖音富二代app下载 菠萝蜜下载app 草莓直播app下载 91香蕉视频下载app 男人本色西瓜视频app下载 水仙直播app下载 成版人短视频下载app视频免费最新 九尾狐视频下载app 探花直播下载app 香蕉视频app下载 宅男之家app下载 草榴视频下载app视频免费最新 后宫下载app视频免费最新 鲍鱼视频下载app视频免费最新 享爱app下载 秀色小抖音app下载 小小影视下载app 雨燕直播下载app 春水堂app下载 Kitty直播app下载 名优馆下载app 爱爱视频app下载 花样视频下载app视频免费最新 橘子直播下载app 菠萝菠萝蜜视频下载app d2天堂app下载 health2下载app 菠萝蜜app下载 香草成视频人下载app 千层浪下载app health2下载app 麻豆传媒视频下载app 成版人抖音富二代下载app视频免费最新 快猫短视频下载app 猫咪视频app下载 久草下载app 樱花下载app 水晶直播下载app 月夜直播app下载 花心社区下载app 梦幻直播下载app 含羞草视频下载app 豌豆直播下载app 趣播下载app